Opioid peptides and gastrointestinal symptoms in autism spectrum disorders

AUTOR(ES)

Lázaro, Cristiane P., Pondé, Milena P., Rodrigues, Luiz E.A.

FONTE

Rev. Bras. Psiquiatr.

DATA DE PUBLICAÇÃO

14/06/2016

RESUMO

Autism spectrum disorders (ASDs) are characterized by deficits in the individual’s ability to socialize, communicate, and use the imagination, in addition to stereotyped behaviors. These disorders have a heterogenous phenotype, both in relation to symptoms and regarding severity. Organic problems related to the gastrointestinal tract are often associated with ASD, including dysbiosis, inflammatory bowel disease, exocrine pancreatic insufficiency, celiac disease, indigestion, malabsorption, food intolerance, and food allergies, leading to vitamin deficiencies and malnutrition. In an attempt to explain the pathophysiology involved in autism, a theory founded on opioid excess has been the focus of various investigations, since it partially explains the symptomatology of the disorder. Another hypothesis has been put forward whereby the probable triggers of ASDs would be related to the presence of bacteria in the bowel, oxidative stress, and intestinal permeability. The present update reviews these hypotheses.

Documentos Relacionados

• Children with autism spectrum disorders
• Autism spectrum disorders: an overview on diagnosis and treatment
• Sleep Behaviors and Sleep Quality in Children with Autism Spectrum Disorders
• Racial/Ethnic Disparities in the Identification of Children With Autism Spectrum Disorders
• LEGO® therapy as an intervention in autism spectrum disorders: an integrative literature review